Trial intelligence / Profile preview

Sertraline versus L-carnitine for intradialytic hypotension in dialysis patients

IRCT20190624043997N1Phase 2Completed

Sponsor
Qazvin University of Medical Sciences
Start
Aug 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of sertraline and levocarnitine in intradialytic hypotension (IDH) (2 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoints: Age, Sex and 3 more. Started Aug 2019; status: completed.

02

Drugs

sertralinelevocarnitine
03

Conditions

intradialytic hypotension (IDH)

Beyond the preview

Go deeper on IRCT20190624043997N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190624043997N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call